Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
EEG reveals that dextroamphetamine improves cognitive control through multiple processes in healthy participants.
Bhakta SG, Cavanagh JF, Talledo JA, Kotz JE, Benster L, Roberts BZ, Nungaray JA, Brigman JL, Light GA, Swerdlow NR, Young JW. Bhakta SG, et al. Among authors: nungaray ja. Neuropsychopharmacology. 2022 Apr;47(5):1029-1036. doi: 10.1038/s41386-021-01257-2. Epub 2022 Jan 18. Neuropsychopharmacology. 2022. PMID: 35042948 Free PMC article. Clinical Trial.
Targeted cognitive training improves auditory and verbal outcomes among treatment refractory schizophrenia patients mandated to residential care.
Thomas ML, Bismark AW, Joshi YB, Tarasenko M, Treichler EBH, Hochberger WC, Zhang W, Nungaray J, Sprock J, Cardoso L, Tiernan K, Attarha M, Braff DL, Vinogradov S, Swerdlow N, Light GA. Thomas ML, et al. Schizophr Res. 2018 Dec;202:378-384. doi: 10.1016/j.schres.2018.07.025. Epub 2018 Jul 25. Schizophr Res. 2018. PMID: 30055883 Free PMC article. Clinical Trial.
Neurophysiologic measures of target engagement predict response to auditory-based cognitive training in treatment refractory schizophrenia.
Hochberger WC, Joshi YB, Thomas ML, Zhang W, Bismark AW, Treichler EBH, Tarasenko M, Nungaray J, Sprock J, Cardoso L, Swerdlow N, Light GA. Hochberger WC, et al. Neuropsychopharmacology. 2019 Feb;44(3):606-612. doi: 10.1038/s41386-018-0256-9. Epub 2018 Oct 30. Neuropsychopharmacology. 2019. PMID: 30377381 Free PMC article. Clinical Trial.
Verbal learning deficits associated with increased anticholinergic burden are attenuated with targeted cognitive training in treatment refractory schizophrenia patients.
Joshi YB, Thomas ML, Hochberger WC, Bismark AW, Treichler EBH, Molina J, Nungaray J, Cardoso L, Sprock J, Swerdlow NR, Light GA. Joshi YB, et al. Schizophr Res. 2019 Jun;208:384-389. doi: 10.1016/j.schres.2019.01.016. Epub 2019 Feb 6. Schizophr Res. 2019. PMID: 30738698 Free PMC article. Clinical Trial.
Anticholinergic Medication Burden-Associated Cognitive Impairment in Schizophrenia.
Joshi YB, Thomas ML, Braff DL, Green MF, Gur RC, Gur RE, Nuechterlein KH, Stone WS, Greenwood TA, Lazzeroni LC, MacDonald LR, Molina JL, Nungaray JA, Radant AD, Silverman JM, Sprock J, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Swerdlow NR, Light GA. Joshi YB, et al. Among authors: nungaray ja. Am J Psychiatry. 2021 Sep 1;178(9):838-847. doi: 10.1176/appi.ajp.2020.20081212. Epub 2021 May 14. Am J Psychiatry. 2021. PMID: 33985348 Free PMC article.
15 results